IBRX - Investigation Alert Baxter International Eagle Pharmaceuticals BioXcel Therapeutics and ImmunityBio: Johnson Fistel LLP Encourages Long-Term Investors to Reach Out for More Information | Benzinga
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws by certain officers of the companies of Baxter International, Inc. (NYSE:BAX), Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX), BioXcel Therapeutics, Inc. (NASDAQ:BTAI), and ImmunityBio, Inc. (NASDAQ:IBRX).
Baxter International, Inc. (NYSE:BAX)
Johnson Fistel, LLP is investigating potential claims on behalf of Baxter International, Inc. (NYSE:BAX).
If you are a current, long-term shareholder of Baxter International, continuously holding your shares since May 25, 2022, you may have standing to hold the company harmless from the alleged harm caused by the Company's officers and directors by making them personally responsible. You may also be able to assist in reforming the Company's corporate governance to prevent future wrongdoing. You can click or copy and paste the link below in a browser to join this action:
https://www.johnsonfistel.com/investigations/baxter-international
Recently a class action lawsuit was filed against Baxter International. According to the complaint, during the class period, defendants materially misrepresented and/or concealed the true nature and severity of supply chain problems it was encountering and the impact they were having on the Company's current and expected earnings. Defendants' failure to disclose Baxter's true problems relating to its supply chain deceived investors about the Company's true financial health and earnings.
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)
Johnson Fistel, LLP is investigating potential claims on behalf of Eagle Pharmaceuticals, Inc. against certain of its officers and directors.
If you are a current, long-term shareholder of Aug. 8, 2023, continuously holding your shares since April 21, 2022, you may have standing to hold the company harmless from the alleged harm caused by the Company's officers and directors by making them personally responsible. You may also be able to assist in reforming the Company's corporate governance to ...